{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:35:44Z","timestamp":1762252544345,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.nmd.2017.04.009","type":"journal-article","created":{"date-parts":[[2017,4,21]],"date-time":"2017-04-21T13:00:19Z","timestamp":1492779619000},"page":"646-649","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Selective or predominant triceps muscle weakness in African\u2013American patients with myasthenia gravis"],"prefix":"10.1016","volume":"27","author":[{"given":"Alon","family":"Abraham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles D.","family":"Kassardjian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans D.","family":"Katzberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Bril","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ari","family":"Breiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2015","series-title":"Neuromuscular disorders","author":"Russell","key":"10.1016\/j.nmd.2017.04.009_bib0010"},{"key":"10.1016\/j.nmd.2017.04.009_bib0015","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/CND.0b013e3181dc7c5b","article-title":"Severe, focal tibialis anterior and triceps brachii weakness in myasthenia gravis: a case report","volume":"12","author":"Rubin","year":"2011","journal-title":"J Clin Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2017.04.009_bib0020","first-page":"58","article-title":"Distribution of extremity muscle weakness in myasthenia gravis: sparing of tibialis anterior muscle","volume":"22","author":"Ozt\u00fcrk","year":"2003","journal-title":"Acta Myol"},{"key":"10.1016\/j.nmd.2017.04.009_bib0025","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1034\/j.1600-0404.2003.00136.x","article-title":"Distal myasthenia gravis frequency and clinical course in a large prospective series","volume":"108","author":"Werner","year":"2003","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.nmd.2017.04.009_bib0030","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3233\/JND-160148","article-title":"Myasthenia gravis: unusual presentations and diagnostic pitfalls","volume":"3","author":"Rodolico","year":"2016","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2017.04.009_bib0035","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/CND.0000000000000121","article-title":"Selective triceps muscle weakness in myasthenia gravis is under-recognized","volume":"18","author":"Domingo","year":"2016","journal-title":"J Clin Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2017.04.009_bib0040","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/mus.25154","article-title":"Characteristics of acetylcholine-receptor-antibody-negative myasthenia gravis in a South African cohort","volume":"54","author":"Huda","year":"2016","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2017.04.009_bib0045","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/mus.21191","article-title":"Racial differences in myasthenia gravis in Alabama","volume":"39","author":"Oh","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2017.04.009_bib0050","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.nmd.2007.07.002","article-title":"Myasthenia gravis in South Africans: racial differences in clinical manifestations","volume":"17","author":"Heckmann","year":"2007","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2017.04.009_bib0055","first-page":"24","article-title":"The influence of muscle group location and race on the relationship between muscle strength and power","volume":"37","author":"Fields","year":"1997","journal-title":"J Sports Med Phys Fitness"},{"key":"10.1016\/j.nmd.2017.04.009_bib0060","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3109\/21678421.2013.770030","article-title":"Epidemiological features of amyotrophic lateral sclerosis in a large clinic-based African American population","volume":"14","author":"Kazamel","year":"2013","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"10.1016\/j.nmd.2017.04.009_bib0065","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ahj.2007.06.008","article-title":"Distribution of creatine kinase in the general population: implications for statin therapy","volume":"154","author":"Brewster","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.nmd.2017.04.009_bib0070","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1468-1331.2010.03012.x","article-title":"EFNS guidelines on the diagnostic approach to pauci- or asymptomatic hyperCKemia","volume":"17","author":"Kyriakides","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2017.04.009_bib0075","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jnnp.36.2.244","article-title":"Neurogenic muscle involvement in myasthenia gravis. A clinical and histopathological study","volume":"36","author":"Oosterhuis","year":"1973","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2017.04.009_bib0080","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jocn.2011.09.022","article-title":"AchR-positive myasthenia gravis with MRI evidence of early muscle atrophy","volume":"19","author":"Zouvelou","year":"2012","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.nmd.2017.04.009_bib0085","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/jnnp.52.10.1121","article-title":"The natural course of myasthenia gravis: a long term follow up study","volume":"52","author":"Oosterhuis","year":"1989","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2017.04.009_bib0090","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.clim.2016.05.003","article-title":"Genetic heterogeneity within the HLA region in three distinct clinical subgroups of myasthenia gravis","volume":"166\u2013167","author":"Saruhan-Direskeneli","year":"2016","journal-title":"Clin Immunol"},{"key":"10.1016\/j.nmd.2017.04.009_bib0095","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1136\/jnnp.40.11.1060","article-title":"Acetylcholinesterase activity and menstrual remissions in myasthenia gravis","volume":"40","author":"Vijayan","year":"1977","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2017.04.009_bib0100","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nmd.2015.10.009","article-title":"Epidemiology of myasthenia gravis in Ontario, Canada","volume":"26","author":"Breiner","year":"2016","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2017.04.009_bib0105","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1196\/annals.1254.057","article-title":"A simple manual muscle test for myasthenia gravis: validation and comparison with the QMG score","volume":"998","author":"Sanders","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.nmd.2017.04.009_bib0110","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/mus.880141111","article-title":"Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barr\u00e9 syndrome","volume":"14","author":"Kleyweg","year":"1991","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2017.04.009_bib0115","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1749-6632.1998.tb11015.x","article-title":"Reliability testing of the quantitative myasthenia gravis score","volume":"841","author":"Barohn","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.nmd.2017.04.009_bib0120","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1212\/WNL.0000000000002971","article-title":"Development and validation of the Myasthenia Gravis Impairment Index","volume":"87","author":"Barnett","year":"2016","journal-title":"Neurology"},{"year":"2011","series-title":"National household survey (NHS) profile","key":"10.1016\/j.nmd.2017.04.009_bib0125"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896617300135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896617300135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:04:41Z","timestamp":1760774681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896617300135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0960896617300135"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2017.04.009","relation":{},"ISSN":["0960-8966"],"issn-type":[{"type":"print","value":"0960-8966"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective or predominant triceps muscle weakness in African\u2013American patients with myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2017.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}